UNSPSC 51434947: Hydrochlorothiazide/quinapril

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434947 Hydrochlorothiazide/quinapril is a Commodity code representing pharmaceutical products used in emergency medical services and acute care settings. State and local procurement under this code focuses on emergency medications and formulary drugs supplied to fire rescue departments, EMS agencies, and related public health responders. The City of Tampa Fire Rescue represents typical end-users; municipalities and special-purpose districts issue solicitations for emergency pharmaceutical supply through competitive bidding processes, often with firm pricing, expiration-date warranties, and rapid delivery requirements tied to operational needs.

The most recent activity appears limited in the sample provided. The City of Tampa's Purchasing Department issued an IFB (Bid No. 26P00188) posted April 24, 2026, for Advanced Life Support Medications for Tampa Fire Rescue with a response date of April 8, 2026—a solicitation covering epinephrine, labetalol, adenosine, and diltiazem injections with an estimated contract value of $40,000.00. The opportunity carried a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount capped at $10,000. Vendors were required to deliver within ten days of order, warrant all materials for 365 days, maintain nine-month expiration dates from acceptance, and submit OSHA-compliant Safety Data Sheets. The contract term was one year with two optional renewal periods plus unilateral extension rights for up to three 30-day periods. Geographic activity in this code appears concentrated in Florida; broader state and local solicitation frequency under this specific commodity code is not clearly established from available recent opportunities.